W omen are less likely than men to have diagnostic and therapeutic procedures for coronary artery disease."2 Use of cardiac catheterization, percutaneous transluminal coronary angioplasty (PTCA), and aortocoronary bypass graft surgery (CABG) in women after acute myocardial infarction (MI) has been reported to be lower than3-8 or equal to9 that in men. These reports did not establish whether differences in use of procedures reflect appropriate clinical practice considering other differences in clinical characteristics between the sexes and whether subsequent mortality in women is adversely affected by the lower rate of use.
The purpose of this study was to assess, in a statewide MI database audited for accuracy, whether women with acute MI have lower rates of diagnostic and therapeutic invasive cardiac procedures and whether different rates tion such as age, sex, race, insurance status, and admission and discharge dates.
Also included in this study were composite variables indicating the presence or absence of diabetes (ICD-9 250.00-250.90), hypertension (ICD-9 401.00-405.99), chronic obstructive pulmonary disease (ICD-9 490.00-496.99), chronic renal disease (ICD-9 580.00-589.99), chronic liver disease (ICD-9 571.00-571.99), anemia (ICD-9 280.00-281.30, 281.90, 282.00, 283.00-285.99), cancer (ICD-9 140.00-208.00), and cerebrovascular disease (ICD-9 430.00-438.99). Two composite indices of mechanical or electrical complications of MI were generated. The first, left ventricular dysfunction (LVD), included presence of any of the following: old MI (ICD-9 412.00), congestive heart failure (CHF) (ICD-9 428.00), left heart failure (ICD-9 428.10), cardiomegaly (ICD-9 429.30), alcoholic cardiomyopathy (ICD-9 425.50), rupture of papillary muscle (ICD-9 429.60), rupture of chordae tendineae (ICD-9 429.50), acquired cardiac septal defects (ICD-9 429.71), hypertensive heart disease with CHF (ICD-9 402.91), cardiogenic shock (ICD-9 785.51), or ventricular aneurysm (ICD-9 414.10). The second, electrical instability (arrhythmia), included presence of cardiac dysrhythmias (ICD-9 427.00), complete atrioventricular block (ICD-9 426.00), unspecified atrioventricular block (ICD-9 426.10), Mobitz (type II) atrioventricular block (ICD-9 426.12), left bundle branch block (ICD-9 426.20), other left bundle branch block (ICD-9 426.30), right bundle branch block (ICD-9 426.40), other and unspecified bundle branch block (ICD-9 426.50), other heart block (ICD-9 426.6), or other specified and unspecified conduction disorders (ICD-9 426.90).
Exclusions
Because of missing century data for date of birth, we excluded records with apparent ages <10 and >99 years (<0.1%). For every patient, only the first recorded (index) infarction that occurred in this database was considered.
Multiple discharges for a given person were identified by internal record linkage. Excluding second and subsequent records for the same patient within the 2 years resulted in the elimination of 6655 (13.5%) of the discharges, leaving 42 595 upon which the present analysis is based.
Patients with acute MI who were hospitalized in another state are not included in this analysis. In addition, the 11 488 
Criteria for Diagnosis of Acute MI
The presence or absence of acute MI was ascertained from criteria modified from the P-Blocker Heart Attack Trial, based on three pieces of information: symptoms, cardiac enzyme levels, and ECG evidence.10 On the basis of this information, each audited chart was classified as indicating definite, probable, recent, or absent MI.
A chart was classified as "definite acute MI" when at least two of the following three criteria were present: (1) definite Q waves (Minnesota Code 1-1-1 through 1-2-7 for Q-QS patterns) developed during the hospitalization, (2) elevated cardiac enzymes as defined below, or (3) symptoms of acute MI associated with newly developed ST elevation (Minnesota Code 9-2) or major T-wave inversion (Minnesota Code 5-1 to 5-2) or ST depression (Minnesota Code 4-1 to 4-2).
The MI was classified as "probable" when (1) typical symptoms, elevated enzymes, and minor ST-(Minnesota Code 4-3 to 4-4) or T-wave changes (5-3 to 5-4) were present in the absence of definite Q waves, or major ST-or T-wave findings (described in 1 and 3 above) on the ECG; (2) serum enzymes were not recorded within 3 days of admission, but there was evidence of typical symptoms as well as the major ST or T abnormalities mentioned in (3) above; or (3) when typical symptoms were not recorded but there was evidence of both enzyme elevation and ECG abnormalities indicating either minor Q-wave (Minnesota Code 1-3-1 to 1-3-6) or major STor T-wave changes mentioned in (3) above.
"Recent" MI was diagnosed when the criteria mentioned under definite or probable MI were present but it could be ascertained from the chart that the infarction had occurred before the index admission but within the past 3 months and verified in the present admission by the presence of continuing Q waves.
When a record could not be classified as indicating definite, probable, or recent infarction, it was classified as having no evidence of infarction ("absent").
The presence of chronic left bundle branch block (ICD-9 7-1-1), complete heart block (6-1), Wolff-Parkinson-White syndrome (6-4-1 or 6-4-2), pacemaker (6) (7) (8) , ventricular fibrillation (8-2-1), or persistent ventricular rhythm (8-2-2 or 8-2-3) invalidated ECG readings. ECGs were coded according to the Minnesota Code and coded on forms similar to those developed by the Atherosclerosis Risk in Communities (ARIC) Study."
Enzyme elevation was considered to be present when measurements within the first 3 days of admission showed an elevation of total creatine kinase, serum glutamic-oxaloacetic transaminase, or lactate dehydrogenase beyond two times the upper normal for the laboratory and the creatine kinase MB fraction was >5%, or "present."
Other Information and Vital Status
Age was considered to be correct if it was within 364 days of the true age of the patient as verified by the chart. All other variables were considered correct if the entries in the database corresponded exactly to the information in the chart.
Vital status follow-up of all patients was performed by matching the MIDAS database with the 1986-1990 single cause of death data files at the New Jersey State Department of Health by use of a specially designed automated record linkage system provided by DataStar, Inc. The methodology is described elsewhere.12 Each patient was followed for a 3-year period from admission or until death if death occurred before 3 years. In-hospital mortality was validated from the 726 audited charts. The accuracy of the record linkage system matching MIDAS and death certificate records was tested in the total cohort (42 595) by in-hospital mortality. The performance of cardiac catheterization, PTCA, and CABG after the index hospitalization was ascertained by matching the MIDAS database with the 1986-1990 UB-82 records for these procedures in New Jersey.
Statistical Analysis
Clinical and demographic characteristics of the groups of interest were compared by Pearson's x2 test for categorical variables and Student's t test for continuous variables. 13 The cumulative incidence of patients who received cardiac catheterization, angioplasty, and CABG were described for men and women, compared by relative risks calculated from the ratio of the two cumulative incidence measures, and stratified by potential confounding variables.'4 Odds ratios adjusted for the potential confounding factors were presented with 95% confidence intervals based on log-linear regression using the maximum-likelihood method.'5 Survival curves were generated based on the Kaplan-Meier method.'6 Plots of the survival curves and the log-log transformation of the survival curves were used to study the survival in subgroups of interest and to evaluate the proportionality assumption for the proportional-hazards regression model. If the proportionality assumption did not hold true for a given covariate, then certain subgroups were excluded or analyzed separately. Proportional- RR indicates relative risk comparing men and women; COPD, chronic obstructive pulmonary disease; and LVD, left ventricular dysfunction. All frequencies were different at P<.001 comparing men and women (x2) except where noted by "n" suffix. Only records of subjects without cancer (3.2% of total) or nephritis (5.0% of total) were used in the above analysis.
32 413 cases (76.1%). Women (17 422) composed 40.9% of the study group and 38.9% of those with acute MI as the principal diagnosis.
Validation of the Diagnosis of Acute MI and Related Variables
The audited sample was representative of the total cohort with respect to age, comorbid conditions, prior history of MI, complications, length of stay, and insurance status. The percentage of patients of white race (nonHispanic) was higher in the audited sample, whereas the percentage of patients in health maintenance organizations and the frequencies of cardiac catheterization and CABG were lower in the audited set (Table 1) .
A definite acute MI was verified in 449 (67.1%) of the 669 charts audited, a probable acute MI in 111 (16.6%), 
(6i (6 C6 : (Fig 1) . Cardiac catheterization was associated consistently with lower mortality in both men and women (Fig 2) .
Mortality rates for all patients were evaluated by multivariate proportional-hazards regression. To maintain the proportionality assumption of this analysis, three age groups (30 to 49, 50 to 69, and 70 to 89 years) were studied, and patients with cancer (3.2%) and nephritis (5.0%) were excluded. Age, left ventricular dysfunction, and diabetes were identified as factors independently associated with a higher mortality rate (Table 6A through 6C). In both men and women, cardiac catheterization was associated with lower mortality. Survival analysis revealed that women had lower unadjusted survival rates than men (Table 7) . This was statistically significant up to age 70 years. Women had a 69% higher death rate in the age group 30 to 49 years, a 21% higher death rate in the age group 50 to 69 years, and a 1% higher rate in the oldest age group. After adjustment for 11 covariates including age, race, comorbidity, complications, and insurance type, singly and in combination, death rates were still higher (although to a lesser extent) in women up to age 70 years, whereas after this age men had higher death rates. The magnitude of difference between the adjusted and unadjusted death rate ratios was greatest in the youngest age group and least in the oldest. If adjustment is made for the performance of cardiac catheterization (or cardiac catheterization and PTCA and CABG) in addition to the other 11 variables, the death rate ratio between men and women up to age 70 years becomes less pronounced and is no longer statistically significant. Similar findings were observed when only cardiovascular mortality was studied and when either total or cardiovascular mortality was examined in the group of patients who had acute MI as the primary diagnosis.
Discussion
Older age, more severe or complicated disease, and differences in comorbid states, socioeconomic status, insurance coverage, presenting symptomatology, and the predictive value of stress tests as well as sex bias have all been proposed as causes of the lower use of procedures in women that has been observed in most studies.1-8, 18 Higher complication rates, higher hospital mortality, and lower success rates of interventions may be additional factors leading to avoidance of procedures in some women. [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] The present study provides additional data indicating that the rate of use of invasive cardiovascular procedures after an acute MI is lower in women and that this difference cannot be completely explained by factors such as age, comorbidity, complications, or insurance type.
Our study extends previous findings by reporting on almost all patients who had MI in a given geographic area and by having established the accuracy of the data and the diagnosis of acute MI by chart review of a random sample of the cases. In our study, the diagnosis of acute MI could not be supported by chart audit in a higher percentage of women than in men. This may offer an additional reason for differences in use, if physicians treat patients with "diagnosed but not proven" MI less aggressively.
The data presented here support the majority of previous reports indicating lower use of invasive procedures in women with acute MI. One study, from a single institution and potentially of inadequate statistical power, reported no difference between men and women in the rate of coronary arteriography after MI. 9 Recognizing that women are less likely to receive cardiac catheterization and revascularization after an acute MI, it is not known whether this represents underuse in women or overuse in men. Our data on survival may shed light on this issue. Cardiac catheterization was associated with lower mortality in both men and women. In the absence of randomization, it is difficult to ascertain whether the better outcome with this invasive strategy is due either to selection of low-risk patients for the procedure or to a beneficial effect of an intervention such as PTCA or CABG that was done on the same or subsequent admission on patients who had catheterization. However, the persistence of the lower risk after adjustment for factors known to influence prognosis, including age, comorbidity, and complications, suggests that the interventions may have a beneficial effect. Randomized clinical trials have shown that an invasive strategy after infarction is appropriate only when required for clinical indications.3031 In SAVE, coronary arteriography and revascularization were performed more commonly in US than in Canadian participating hospitals, but mortality was not different. The rate of cardiac catheterization in SAVE was much higher than in the present study.32 In this study, the higher adjusted death rate of women compared with men up to age 70 years may suggest that the underuse of (beneficial) procedures is associated with a less favorable outcome in women. The fact that the difference in death rates between men and women is diminished after adjustment for the performance of invasive procedures implies that the association between sex and death rate was confounded by the different rates of performance of cardiac catheterization. A higher long-term mortality in women after acute MI has been reported by previous investigators.33 -35 Other studies have indicated a poorer long-term survival in men. [36] [37] [38] [39] In the present study, a higher adjusted death rate was observed in men only in the oldest age group (70 to 89 years). This is consonant with a recent report in the Medicare population in which adjusted mortality was higher in men only in the age groups >74 years.5 In this age group, the rates for cardiac catheter-ization were low, and factors other than the 11 variables used for adjustment may become important. The low rate of cardiac catheterization and PTCA (and CABG) in both men and women may potentially be insufficient to markedly affect overall prognosis in the total cohort. In any case, overuse of invasive procedures in men with acute MI based on 3-year survival rates is not supported by the data presented. On the contrary, a significant underuse in women (compared with men) is evident, and a suggestion is present that it is associated with adverse long-term outcomes.
Alternatively, in the majority of patients, a significant long-term benefit might not derive from these procedures, which may instead be markers of better prognosis unrelated to the confounding variables considered in our analysis. Cardiac catheterization may be associated with improved prognosis by allowing revascularization procedures in the index or subsequent hospital admission, by facilitating better medical management, or by being related to better physician and patient characteristics.
The conclusions of this study are strengthened by the fact that similar results are obtained when diagnostic and therapeutic procedures performed during the admission for the index infarction or at 3 months or throughout the follow-up were considered. The retrospective nature of the study and the lack of quantitative measures of coronary anatomy, LV function, risk factors, thrombolytic therapy, and postdischarge management are limitations of the study. In addition, the study pertains to practice more than 5 years ago.
Nevertheless, our data indicate that women with acute MI are less likely to have interventions than men. This may lead to less favorable long-term outcome, especially in the younger age groups (up to 70 years). Invasive procedures are associated with better prognosis, although this may be due in part to selection of low-risk patients for these procedures.
